Information Provided By:
Fly News Breaks for January 16, 2019
UNH
Jan 16, 2019 | 07:24 EDT
Oppenheimer analyst Michael Wiederhorn raised his price target for UnitedHealth to $305 from $300 after the company reported quarterly results. The analyst notes that although investors were concerned about the Medicaid/MLR weakness, the overall results were strong, driven by Optum, which contributed about 60% to Q4 earnings. Since he expects this business to continue to drive results, the analyst reiterates an Outperform rating and would continue to be a long-term buyer of the stock.
News For UNH From the Last 2 Days
UNH
Mar 28, 2024 | 06:51 EDT
BofA downgraded Molina Healthcare (MOH) to Underperform from Neutral with a $439 price target. The firm, which is concerned that Molina and the Medicaid industry more broadly are likely to face rate pressure after a period of elevated margins, sees a less attractive risk/reward for Molina compared to other insurers the firm covers, the analyst tells investors. Molina is now trading roughly at parity with the firm's top pick in the space, UnitedHealth (UNH), compared to a 22% discount that had been seen over the last five years, helping to underscore the firm's view that "sentiment for Medicaid is nearing a top just at a time when Medicare is reaching a bottom," the analyst added.